Year: 2026
-
Fructose Uptake in Immune Cells Promotes Glioblastoma Growth
Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor microenvironment metabolize fructose to suppress immune responses and promote tumor growth, according to a recent study published in the Proceedings of the National Academy of Sciences.
-
Bariatric Surgery in Adolescents ‘Reprograms’ Kidney Biology to Promote Recovery
Scientists have discovered novel molecular mechanisms that contribute to recovery from diabetic kidney following bariatric surgery in adolescents with type 2 diabetes and obesity, mechanisms that may serve as potential targets for non-surgical treatments for diabetic kidney disease, according to a multi-institutional study published in The Journal of Clinical Investigation.
-
Feinberg Students Celebrate Match Day 2026
Anticipation and applause filled the air on Friday, March 20, as Feinberg students gathered with family, friends and faculty to learn where they will begin the next phase of their medical training during Match Day 2026.
-
Schizophrenia Study Finds New Biomarker, Drug Candidate to Treat Cognitive Symptoms
A new Northwestern study in humans and mice has discovered a novel biomarker of schizophrenia that could also serve as a new drug candidate to treat the cognitive symptoms of the disorder.
-
Premature Menopause Raises Long-Term Heart Risk by 40 Percent
Women who enter natural menopause before age 40 face about a 40 percent higher lifetime risk of developing coronary heart disease than women who experience menopause later, according to a large Northwestern Medicine study.
-
Advancing Epilepsy Research Through Genetic Insights
Epilepsy is one of the most common neurological disorders affecting nearly one percent of people worldwide. The Department of Pharmacology at Feinberg is leading research to understand the genetic causes of childhood-onset epilepsy, and to investigate what is happening perinatally to brain development in these cases.
-
FDA-Approved Compound Promotes Neuroprotective Effects in Parkinson’s Disease
Northwestern Medicine scientists have discovered an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson’s disease, according to a recent study published in The Journal of Clinical Investigation.
-
Calcium Signaling Channels Regulate Neuroinflammation and Motivation
Northwestern Medicine scientists have discovered how calcium signaling channels in the brain’s immune cells regulate neuroinflammation and promote the development of behaviors associated with affective mood disorders, according to a recent study published in Science Signaling.
-
First Gene Regulation Clinical Trials for Epilepsy Show Promising Results
A first‑ever gene‑regulation therapy tested in early‑phase clinical trials co‑led by Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has proven safe in children with Dravet syndrome who have exhausted conventional treatment options, according to a study published in the New England Journal of Medicine.
-
Automated Screening and Education Increases Urinary Incontinence Diagnoses
Implementing an automated urinary incontinence screening and educational program in primary care practices significantly increased awareness and treatment referrals in women with the condition, according to a recent study published in JAMA Internal Medicine.
